And then point number 3 relative to our cash flow forecast On a free cash flow basis reported, we're expecting to be about $100,000,000 lower Then our original guide, as a reminder, we had a $600,000,000 free cash flow for this year. We're forecasting 4.75 As a reminder, within that $475,000,000 there are $450,000,000 Reg G charges. So on an adjusted basis, We expect to be over $900,000,000 that compares to the $1,000,000,000 we started off. That $450,000,000 by the way includes $250,000,000 of transaction So it's taxes, it's M and A, separation fees for the microbial control, FSI and Savary Solutions. Of the residual $75,000,000 is related to the final integration activities with DuPont this year and there's another $100,000,000 plus That are largely related to the restructure that we performed this year.